New Breast Cancer Drug Launched in UK

.

New Breast Cancer Drug Launched in UK

Patients suffering from breast cancer now have a reason to smile. A new drug produced in Japan is now all set to hit the stores in the UK. It is made by Japanese drug maker Eisai and it is a marine-based drug.

The European drug regulators passed this drug for the aid of patients suffering from the advanced stages of breast cancer. The drug is suitable for those patients who have had at least two chemotherapies but still had no effect on the cancer.

The UK has a high rate of breast cancer patients and as many as 16% deaths in the country occur due to it. As many as 30% of the women who are previously diagnosed with early stage cancer later tend to develop its advanced stages, which becomes somewhat incurable.

With the new drug in the market, there is a way for many new possibilities. The drug-maker, Eisai, is of the view that this is the first single agent treatment that has shown positive results in the patients suffering from the advanced stages of the disease.

According to Consultant Medical Oncologist Andrew Wardley Halaven, the new drug "addresses an urgent need for new treatment options for women with advanced breast cancer who have previously received multiple treatments”.


Latest News

Though Wages in Japan Increase But It’s not Enough to Beat Inflation
Jack Ma Prepares for Second Alibaba IPO
RBA Feels Currency Overrated: Keeps Record Low Benchmark Rate
U.S. Business Lobby Express Concerns Saying Antitrust Probes in China Unfair
First dengue fever outbreak in 70 years in Japan
Rise in skin cancer due to cheap holidays
Cardio and wine is a great combination
Surrogacy is a form of exploitation: Ekman
Cuba Trims Down on Amount of Goods Which can be Carried by Travellers
Barclays Will Sell Its Spanish Businesses To CaixaBank In a Deal of 800 Million
Withdrawal in China’s Purchasing Managers' Index Amplifies Calls for Policy Easi
The Ukraine Mayhem Leads Euro to a Fresh One Year Low